Internal Medicine News articles from November 2006

Internal Medicine News archives from November 2006

Doctors Sue over 'quality' exclusion.(News)
November 1, 2006... In a move that challenges methods used to assess physician performance, six Washington state physicians and the Washington State Medical Association have filed suit against Regence BlueShield after the insurer used internal quality data to...

Exenatide boosts glycemic control, weight reduction: advantages over biphasic insulin cited.(News)
November 1, 2006... COPENHAGEN -- Exenatide provides sustained improvements in glycemic control and progressive decreases in body weight for up to 2 years in patients with type 2 diabetes, Dr. Robert R. Henry and his associates reported in a poster at the annual...

PPI with low-dose aspirin cuts ulcer formation 71%.(News)
November 1, 2006... BARCELONA -- Concomitant proton pump inhibitor therapy reduced by 71% the relative risk of gastroduodenal ulcers in patients on continuous low-dose aspirin for secondary cardiovascular or cerebrovascular prevention in a large randomized trial,...

Type 2 diabetics can achieve normal life span.(News)(Report)
November 1, 2006... COPENHAGEN -- Here's some good news you can give your patients with type 2 diabetes: If their blood sugars are well controlled and they don't smoke, there's a good chance they'll live a normal life span. That encouraging finding, from an...

FDA approves new HIV-1 test for laboratories.(News)(Brief article)
November 1, 2006... An assay that detects the RNA of HIV-1 has been approved by the Food and Drug Administration, making a gene-based test for the virus available to medical diagnostic laboratories for the first time. On Oct. 5, the FDA announced approval of...

IOM committee urges Medicare to phase in pay-for-performance system.(News)
November 1, 2006... The U.S. Department of Health and Human Services should gradually replace Medicare's payment system with a pay-for-performance system that would reward providers for efficiency along with patient-centered, quality care, according to a report...

FDA warning targets drug Web sites.(News)
November 1, 2006... Consumers should not buy or use prescription drugs obtained from certain Canadian Web sites allegedly selling counterfeit versions of Lipitor, Propecia, a breast cancer drug, and other prescription drugs, according to a warning issued by the...

Major event rates similar for all stents at 5 years.(News)(Conference news)
November 1, 2006... BARCELONA -- The long-term safety of drug-eluting coronary stents generally lagged behind that of bare-metal stents in the extended follow-up of two clinical studies presented at a joint meeting of the European Society of Cardiology and the...

Thrombosis risk of drug-eluting stents remains for 3 years.(News)
November 1, 2006... BARCELONA -- The rate of late stent thrombosis remained steady at 0.6% per year from 30 days through 3 years after drug-eluting stent implantation in a large cohort study, Dr. Peter Wenaweser reported at the joint congress of the European...

Gemifloxacin voted down for sinusitis.(News)
November 1, 2006... GAITHERSBURG, MD. -- A Food and Drug Administration advisory panel has recommended against approving the fluoroquinolone gemifloxacin for treating acute bacterial sinusitis, because of the noninferiority design of the studies submitted for...

FluLaval.(NEW & APPROVED)
November 1, 2006... FluLaval (Influenza virus vaccine, ID Biomedical Corporation/GlaxoSmithKline) An injectable influenza vaccine approved for active immunization of adults ages 18 and older against influenza disease caused by influenza virus subtypes A...

Remicade.(NEW & APPROVED)
November 1, 2006... Remicade (infliximab, Centocor, Inc.) A tumor necrosis factor-[alpha] (TNF-[alpha]) blocking agent approved for treating adults with chronic severe (extensive and/or disabling) plaque psoriasis who are candidates for systemic therapy...

Making progress against STDs.(GUEST EDITORIAL)(Viewpoint essay)
November 1, 2006... Nearly a decade has passed since the Institute of Medicine issued its landmark report, "The Hidden Epidemic: Confronting Sexually Transmitted Diseases." The institute envisioned a national system for the prevention of sexually transmitted...

Is cryoablation better than radiofrequency ablation for a small renal mass?(POINT/COUNTERPOINT)
November 1, 2006... Radiofrequency ablation is preferable. Radiofrequency ablation (RFA), a high-tech version of electrocautery devices, kills cells using temperatures above 70[degrees]C. Radiofrequency is the preferred technology for most liver, breast,...

Graphics not clear to the color blind.(LETTERS)(Letter to the editor)
November 1, 2006... I would like to point out that up to 10% of American males are color blind. As one of those males, it would be very easy for me to misinterpret a graphic that accompanied one or your recent reports ("Several Crohn's Drugs Safe During Pregnancy,...

Despair at the end of life.(LETTERS)(Letter to the editor)
November 1, 2006... The vast majority of physicians and the public believe that when death is imminent, technology should continue. Many physicians manipulate their patients at the end of life with feeding tubes and tracheostomies, and then move on to the next...

Corrections.(Correction notice)
November 1, 2006... The story "Innovative Imaging Allows Earlier AD Diagnosis" (INTERNAL MEDICINE, Aug. 15, 2006, p. 15) confused the distinct differences between the two imaging compounds: a radiotracer known as [18F]FDDNP and Pittsburgh Imaging Compound B....

Leuprolide acetate may forestall decline in AD.(Neurology)
November 1, 2006... MADRID -- Leuprolide acetate may help forestall functional decline in patients with mild to moderate Alzheimer's disease, Christopher W. Gregory, Ph.D., reported in a poster at the 10th International Conference on Alzheimer's Disease and...

Hypersexuality in AD resolves with oxcarbazepine.(Neurology)(Brief article)
November 1, 2006... MADRID -- Oxcarbazepine appears to significantly decrease hypersexual behavior in patients with Alzheimer's disease, Dr. Joshua Shua-Haim reported in a poster at the 10th International Conference on Alzheimer's Disease and Related Disorders....

Hyperbaric oxygen offers hope after brain injury.(Neurology)
November 1, 2006... FORT LAUDERDALE, FLA. -- They come in after a near drowning, near hanging, umbilical cord strangulation, cardiac arrest, or carbon monoxide poisoning. They have anoxic ischemic encephalopathy, and their families are seeking the hope offered by...

Gulf War vets may face increased risk of ALS.(Neurology)
November 1, 2006... Veterans of the 1990-1991 Persian Gulf War may be at increased risk for developing psychological conditions, and their service may be associated with a greater chance of developing amyotrophic lateral sclerosis, according to a report by the...

Rivastigmine is good first-line drug for Parkinson's dementia.(Neurology)(Report)
November 1, 2006... MADRID -- Rivastigmine should be the first option for treating dementia and associated behavioral symptoms in Parkinson's disease, with the atypical antipsychotics reserved for unresponsive patients, Dr. Murat Emre said at the 10th...

Third carotid stent with emboli filter gets nod.(Neurology)
November 1, 2006... The Food and Drug Administration has approved the Precise Nitinol Stent System for use with an emboli-trapping device, for treating patients "at high risk for adverse events from carotid endarterectomy," who require carotid revascularization...

Carotid stenting outcomes linked to learning curve.(Neurology)
November 1, 2006... PHILADELPHIA -- Minimizing the complications from carotid artery stenting may require accumulating experience with up to 200 patients, according to the records at a single medical center in Italy. An analysis of the correlates of death or...

Hyperbaric oxygen may reduce hyperperfusion after stroke.(Neurology)
November 1, 2006... FORT LAUDERDALE, FLA. -- Hyperbaric oxygen therapy may be able to reduce brain hyperperfusion associated with cerebral anoxia following a stroke, according to findings from a small study presented at a symposium on hyperbaric oxygen therapy....

Atorvastatin cuts stroke risk.(CLINICAL CAPSULES)(Brief article)
November 1, 2006... Daily high-dose atorvastatin reduces the risk of stroke in patients who have had a recent stroke or transient ischemic attack, reported Dr. Pierre Amarenco of Denis Diderot University, Paris, and his associates in the SPARCL trial. "On the...

Carotid artery stenting vs. depression.(CLINICAL CAPSULES)(Brief article)
November 1, 2006... Carotid artery stenting appears to lessen depression associated with severe stenosis of the carotid artery in older patients. After stent placement, the frequency of depressive symptoms dropped from 34% to 10% among patients with high-grade...

Concussions and cognitive function.(CLINICAL CAPSULES)(Brief article)
November 1, 2006... Concussion history does not predict performance on computerized neurocognitive assessments, reported Steven P. Broglio, Ph.D., of the University of Illinois, Urbana-Champaign, and his colleagues. Using data from an ongoing retrospective...

Sleep maintenance shown to decline in old age.(Psychiatry)
November 1, 2006... PARIS -- Pooled data from two clinical trials of eszopiclone suggest that elderly insomniacs have more difficulty staying asleep than falling asleep, Judy Caron, Ph.D., reported at the annual congress of the European College of...

Caffeine may aid cognition in OSA patients.(Psychiatry)(Clinical report)
November 1, 2006... SALT LAKE CITY -- Increased caffeine intake was associated with better cognitive functioning in patients with obstructive sleep apnea, according to the results of a small study. In 42 patients with untreated obstructive sleep apnea, a...

Smoking quit lines may ease doctors' workloads.(Psychiatry)
November 1, 2006... WASHINGTON -- The opportunity to refer patients to a telephone quit line encourages physicians to talk to their patients about quitting smoking, Dr. Stephen Rothemich said at a conference on tobacco control sponsored by the American Cancer...

Why smokers are hesitant to talk to a physician about quitting.(DATA WATCH)(Report)(Brief article)
November 1, 2006... Why Smokers Are Hesitant to Talk to A Physician About Quitting I know smoking is bad for me 80% I don't want a lecture 67% I'd rather try to quit on my own 61% I'm too embarrassed ...

What reduces smokers' reluctance to talk to a physician about quitting.(DATA WATCH)(Brief article)
November 1, 2006... What Reduces Smokers' Reluctance to Talk to a Physician About Quitting Having a smoking-related illness 62% Having better rapport with doctor 37% Feeling that doctor really cares ...

Smoking rates remain above 40% in 20 blue-collar occupations.(Psychiatry)(Brief article)
November 1, 2006... WASHINGTON -- Significantly fewer white-collar workers than blue-collar workers are smokers, according to National Health Interview Survey data from more than 140,000 respondents. Pooled smoking data from 1997 to 2004 showed the highest...

Cigarette nicotine levels increased 10% in 6 years.(Psychiatry)(Report)(Brief article)
November 1, 2006... Quitting smoking may be harder than it used to be, according to a report from the Massachusetts Department of Public Health. The report, based on data on nicotine yields between 1998 and 2004 from all tobacco companies that sell cigarettes...

FDA panel nixes breast cancer screening device.(Women's Health)
November 1, 2006... GAITHERSBURG, MD. -- A device intended for use in the annual breast cancer screening of women aged 30-39 years who have no family history of the disease and a negative clinical breast examination was found not effective in a unanimous vote by...

For progression-free survival, combo beats anastrozole alone in metastatic breast cancer.(Women's Health)
November 1, 2006... Trastuzumab combined with anastrozole in women with metastatic breast cancer whose disease was both estrogen receptor-positive and positive for the HER2 gene mutation was associated with double the progression-free survival and nearly 5 more...

Anastrozole lowers bone density, but cuts breast cancer recurrence.(Women's Health)
November 1, 2006... ATLANTA -- Anastrozole decreased bone mineral density by an average of 6.1% in the lumbar spine and 7.2% in the hip over the 5 years that postmenopausal breast cancer patients were enrolled in a study presented by Dr. Robert E. Coleman at the...

Yoga boosts quality of life during breast Ca irradiation.(Women's Health)
November 1, 2006... ATLANTA -- Participation in a yoga program during breast cancer treatment is feasible and may improve quality of life, Lorenzo Cohen, Ph.D., reported at the annual meeting of the American Society of Clinical Oncology. The study, designed...

Hormone therapy debate continues post WHI: the effects of postmenopausal HT on both heart disease risk and breast cancer risk remain unclear.(Women's Health)
November 1, 2006... LA JOLLA, CALIF. -- It's time to rekindle enthusiasm for postmenopausal hormone therapy, Dr. Leon Speroff said at the annual meeting of the Association of Reproductive Health Professionals. "In my view, postmenopausal hormone therapy is in...

Contraception in women with medical conditions.(THE EFFECTIVE PHYSICIAN)
November 1, 2006... Background Hormonal contraception products are used by women with a range of ages and degrees of health status. Internists often manage comorbid conditions in patients who use these preparations. The American College of Obstetricians and...

N-9 spermicides safe for women at low STI risk.(Women's Health)
November 1, 2006... LA JOLLA, CALIF. -- Spermicides containing nonoxynol-9 are a safe option for women who are at low risk of acquiring sexually transmitted infections, according to a study from the University of Pittsburgh. Use of an N-9 spermicide was...

Gestational diabetes risk cut by 72% with physical activity.(Women's Health)(Brief article)
November 1, 2006... WASHINGTON -- Physical activity during pregnancy in previously inactive women is associated with reduced risk of gestational diabetes, according to a review of women in the National Maternal and Infant Health Survey. In the study of 3,770...

Successful uterine artery embolization explained.(Women's Health)(Brief article)
November 1, 2006... ROME -- The dominant factor in early or late failure of uterine artery embolization is incomplete devascularization of fibroids, Dr. Thomas J. Kroencke said at the annual meeting of the Cardiovascular and Interventional Radiological Society of...

Lifestyle can cut weight, CVD risk in diabetes: the intensive lifestyle intervention includes diet and fitness; 97% of subjects returned at 1 year follow-up.(Endocrinology)
November 1, 2006... WASHINGTON -- One-year data obtained from a large, federally funded trial have shown that intensive lifestyle intervention can produce significant weight loss and reduce cardiovascular risk factors in patients with type 2 diabetes, Dr. F....

Intensive primary care intervention improves diabetes care, outcomes.(Endocrinology)(Report)
November 1, 2006... WASHINGTON -- An intensive multicomponent intervention in primary care settings can improve both clinical performance measures and outcomes for patients with diabetes, Dr. Kevin A. Peterson reported at the annual scientific sessions of the...

Psychological needs of diabetic patients often not addressed.(Endocrinology)
November 1, 2006... WASHINGTON -- Many patients with diabetes say they need help coping with the disease, but too few have these psychological needs addressed during initial diabetes education sessions, Mark Peyrot, Ph.D., reported at the annual scientific...

Youths using pumps can avoid exercise-induced hypoglycemia.(Endocrinology)
November 1, 2006... KEYSTONE, COLO. -- Stopping basal insulin during exercise sharply reduces the risk of hypoglycemia in children and adolescents with type 1 diabetes on insulin pump therapy, Dr. Rosanna Fiallo-Scharer reported at a conference on the management...

Sprinting after exercise dampens hypoglycemia.(Endocrinology)
November 1, 2006... KEYSTONE, COLO. -- A novel strategy to prevent exercise-related hypoglycemia in type 1 diabetic patients involves having them finish a moderate-intensity workout with an all-out 10-second sprint, Dr. Rosanna Fiallo-Scharer said at a conference...

Lipid composition may explain CVD risk in type 1 diabetes.(Endocrinology)
November 1, 2006... KEYSTONE, COLO. -- The size and composition of their lipids--rather than classically abnormal lipid levels--may explain the dyslipidemia of many type 1 diabetes patients and why they end up with cardiovascular disease, Dr. Robert H. Eckel said...

Prescribe chewing gum for glossodynia.(Dermatology)
November 1, 2006... WINNIPEG, MAN. -- Emotional stress underlies most cases of glossodynia, and--after ruling out dermatologic causes ranging from contact allergy to cancer--the best prescription for patients may be relaxation, Dr. Robert Conklin said at the...

Gender differences seen in melanoma of foot.(Dermatology)
November 1, 2006... SAN DIEGO -- Melanoma of the foot and ankle occurred far more commonly in women than in men, but men were more likely to have thicker tumors associated with a worse prognosis, Dr. Hugh T. Greenway said at the annual meeting of the California...

Fungal skin infections look odd, evade diagnosis: when faced with a diagnostic dilemma, think fungi, especially in patients with compromised immunity.(Dermatology)
November 1, 2006... SAN DIEGO -- The rise in the incidence of unusual fungi, especially in immunocompromised individuals, is complicating the diagnosis of cutaneous mycoses, said Dr. Ted Rosen at the American Academy of Dermatology's Academy 2006 conference. ...

New sunscreens will offer better UVA protection.(Dermatology)
November 1, 2006... SAN DIEGO -- The arrival of two new sunscreen formulations on the U.S. market will undoubtedly lead to better UVA protection for patients, but it remains to be seen whether either will stack up to products available in Canada and Europe, Dr....

Cancer guidelines focus on weight management.(Clinical Rounds)
November 1, 2006... Advising patients to maintain a healthy weight can help them reduce their risk for several kinds of cancer, according to updated guidelines from the American Cancer Society. The new guidelines focus on maintaining a healthy weight...

BladderChek cancer screen.(PRODUCTS)
November 1, 2006... Matritech's BladderChek test is approved for in-office use in order to diagnose and monitor bladder cancer. The screening method, which on average costs less than $30, detects elevated levels of the NMP22 protein marker in a urine sample. For...

Pocket-size diabetes Journal.(PRODUCTS)(My Pocket Doctor: Diabetic Reference Guide and Journal)(Brief article)
November 1, 2006... "My Pocket Doctor: Diabetic Reference Guide and Journal" contains information geared primarily toward newly diagnosed diabetes patients, including disease terms, an emergency I.D. card, blood glucose testing, insulin, medications, and lifestyle...

IM Self-Assessment tool.(PRODUCTS)(internal medicine)(Brief article)
November 1, 2006... The American College of Physicians has released Part A of the 14th edition of its Medical Knowledge Self-Assessment Program (MKSAP). Part A includes the foundations of internal medicine, cardiovascular medicine, gastroenterology and hepatology,...

Higher dose of Diovan HCT approved.(PRODUCTS)(hydrochlorothiazide)(Brief article)
November 1, 2006... The FDA has approved the higher-dose formulations of Diovan HCT (valsartan/hydrochlorothiazide) for patients with high blood pressure. The medication is a combination of Diovan (valsartan), an angiotensin receptor blocker, and the diuretic...

Portable nebulizer system.(PRODUCTS)(MiniElite)(Brief article)
November 1, 2006... The MiniElite compressor nebulizer system is designed for use by active patients who want to take their aerosol treatments on the go. The small, lightweight (less than 1 pound) compressor can be operated on three different electric power...

New vaginitis test available.(PRODUCTS)(Fem-V by Synova Healthcare Group Inc.)(Brief article)
November 1, 2006... The Fem-V vaginal infection test is available over the counter to help a woman determine if symptoms of a vaginal infection merit a trip to her physician. For more information, contact Synova Healthcare Group Inc. by sending an e-mail to...

Remicade receives new indication.(PRODUCTS)(Brief article)
November 1, 2006... Remicade (infliximab) is now indicated to slow the progression of joint damage and improve physical function in patients with psoriatic arthritis. The recommended intravenous dosage is 5 mg/kg, with similar doses to be administered 2 and 6...

Ulnar nerve protector.(PRODUCTS)(Brief article)
November 1, 2006... A reusable ulnar nerve protector can prevent ulnar nerve compression and protect the environment. The protector is made from egg-crate foam and has a waterproof, vinyl covering that can be disinfected with hospital detergents. The fit adjusts...

Disposable endocervical curet.(PRODUCTS)(FemECC by FemSuite LLC)(Brief article)
November 1, 2006... The FemECC is a disposable endocervical curet for use in obtaining tissue samples for histologic analysis. The device's screw-like design is intended to better obtain contiguous samples. The curet is available in regular and large sizes. For...

New lab coat styles available.(PRODUCTS)(Brief article)
November 1, 2006... Doc's Duds has added two new lab coat styles to its product line, the Wayne and the Betty. The lab coats are manufactured to inhibit the spread of bacterial and fungal nosocomial infections. For more information, visit www.docsduds.com or call...

Medical examination lamp.(PRODUCTS)
November 1, 2006... The RLM series magnifying lamp/examination light features an ergonomic, easy-to-grip handle, a 22-W fluorescent ring light, and a distortion-free magnification of 5 diopters (2.25X) with an optional 3X add-on magnifying lens. It can be used in...

Criteria elucidate the role of cardiac CT and MR.(Cardiovascular Medicine)
November 1, 2006... To help physicians keep up with ever-changing imaging technology, the American College of Cardiology Foundation and key specialty societies have released appropriateness criteria for the use of cardiac CT and MR. These are rapidly emerging...

Supplemental arm pumping puts adenosine testing on par with exercise stress test.(Cardiovascular Medicine)
November 1, 2006... MONTREAL -- Adenosine stress testing with supplemental arm pumping exercise had the same diagnostic accuracy as exercise stress testing in detecting significant coronary artery disease in a study of 302 patients. The results validate a...

Sleep apnea found in 70% of patients with coronary disease.(Cardiovascular Medicine)(Brief article)
November 1, 2006... SALT LAKE CITY -- The prevalence of obstructive sleep apnea in patients with coronary heart disease may be higher than previously thought, according to data presented at the annual meeting of the Associated Professional Sleep Societies. In...

Metabolic syndrome criteria miss at-risk blacks.(Cardiovascular Medicine)
November 1, 2006... ATLANTA -- Current sets of criteria for diagnosing metabolic syndrome fail to identify many African American patients at increased risk of cardiovascular disease and diabetes, said Dr. Anne E. Sumner in a presentation given at a meeting...

Metabolic syndrome associated with increased risks of atrial fib and stroke.(Cardiovascular Medicine)
November 1, 2006... BARCELONA -- Patients with metabolic syndrome have an increased risk of developing atrial fibrillation compared with patients with a single risk factor for cardiovascular disease, based on an analysis of more than 13,000 patients. ...

Lipid biomarker linked to higher cardiovascular risk.(Cardiovascular Medicine)
November 1, 2006... BARCELONA -- Elevated lipoprotein-associated phospholipase A2 and metabolic syndrome are additive in their predictive power for future cardiovascular events, Dr. Margaretha Persson reported at the joint congress of the European Society of...

DVT requires aggressive Tx to avoid chronic syndrome.(Cardiovascular Medicine)
November 1, 2006... ROME -- Many physicians outside of interventional radiology are inappropriately complacent regarding the long-term sequelae of deep vein thrombosis in the lower extremities, speakers said at the annual meeting of the Cardiovascular and...

Facilitated thrombolysis devices speed DVT therapy, reduce costs.(Cardiovascular Medicine)(deep vein thrombosis )
November 1, 2006... ROME -- Several relatively new percutaneous pharmacomechanical devices may have a major impact on the treatment of deep vein thrombosis, speakers predicted at the annual meeting of the Cardiovascular and Radiological Interventional Society of...

Lipoprotein (a) and CV risk in women.(CLINICAL CAPSULES)(Brief article)
November 1, 2006... High levels of lipoprotein (a) are associated with increased cardiovascular risk in healthy women, particularly in those with high levels of LDL cholesterol, according to researchers at Harvard Medical School, Boston. Dr. Jacqueline Suk...

Impact of long QT syndrome.(CLINICAL CAPSULES)(Brief article)
November 1, 2006... Factors that predict a high risk of life-threatening events in adolescents with the hereditary long QT syndrome are duration of the QT interval, timing and frequency of recent syncope, and male gender, according to a study by Dr. Jenny B. Hobbs...

MI risk higher in men with gout.(CLINICAL CAPSULES)(Brief article)
November 1, 2006... Men with a history of gouty arthritis have a significantly higher risk of acute myocardial infarction, reported Dr. Eswar Krishnan of the University of Pittsburgh and his associates. "This study is the first to show that among men with no...

New drugs could slow rise in fungal infections.(Infectious Diseases)
November 1, 2006... SAN DIEGO -- The incidence of cutaneous fungal infections is on the rise in the United States, and the old standby antifungal drugs aren't working as well as they used to, Dr. Ted Rosen said at the American Academy of Dermatology's Academy 2006...

Noxafil wins approval for the prevention of invasive Aspergillus, Candida infections.(Infectious Diseases)
November 1, 2006... The Food and Drug Administration has approved a new drug intended for the prevention of Aspergillus and Candida fungal infections in immunocompromised patients. Posaconazole, which will be marketed as Noxafil by Schering-Plough, was...

Bacterial contamination prompts recall of Perineal Washcloths.(Infectious Diseases)(Brief article)
November 1, 2006... Certain lots of Comfort Shield Perineal Care Washcloths have been recalled because of contamination with Burkholderia cepacia. The bacteria can cause serious infections including pneumonia and bacterial sepsis in immunocompromised...

Holiday from HIV therapy safe, helpful.(Infectious Diseases)(Clinical report)
November 1, 2006... GENEVA -- Giving HIV-infected patients a holiday from their drugs may safely reduce the side effects and costs of treatment, according to results from the Staccato study, a prospective, open-label, randomized trial done in Thailand,...

Serosorting may decrease HIV spread.(Infectious Diseases)
November 1, 2006... WASHINGTON -- Serosorting--the selection of sex practices based on a partner's known or perceived HIV status--is becoming more popular among men who have sex with men, Dr. Robert M. Grant said at the Ryan White CARE Act clinical meeting on HIV...

Genomic tools take aim at infectious diseases.(Infectious Diseases)
November 1, 2006... MONTEREY, CALIF. -- Clinically useful tests are on the horizon to detect changes in DNA that can alter health outcomes for patients with infectious diseases, Dr. Michael F. Murray said. At the annual meeting of the Infectious Diseases...

MRSA linked to higher failure rates in diabetic foot infections.(Infectious Diseases)(Report)
November 1, 2006... SAN FRANCISCO -- The isolation of methicillin-resistant Staphylococcus aureus, either alone or as part of a polymicrobial infection, was associated with treatment failure in 35% of patients with a diabetic foot infection, Dr. Matthew E. Falagas...